MediWound Ltd. (MDWD) to Release Earnings on Thursday

MediWound Ltd. (NASDAQ:MDWD) is scheduled to be releasing its earnings data before the market opens on Thursday, November 16th. Analysts expect MediWound to post earnings of ($0.19) per share for the quarter.

MediWound Ltd. (MDWD) opened at $4.30 on Tuesday. MediWound Ltd. has a 1-year low of $4.25 and a 1-year high of $8.25.

A number of research firms have weighed in on MDWD. Zacks Investment Research raised MediWound from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 2nd. Jefferies Group LLC set a $10.00 target price on MediWound and gave the company a “buy” rating in a report on Friday, August 25th. Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $10.00 target price on shares of MediWound in a report on Monday, September 18th. ValuEngine raised MediWound from a “strong sell” rating to a “sell” rating in a report on Friday, October 20th. Finally, Cowen and Company began coverage on MediWound in a report on Thursday, September 28th. They issued an “outperform” rating and a $9.00 target price on the stock. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $9.15.

COPYRIGHT VIOLATION WARNING: This report was originally published by Markets Daily and is the property of of Markets Daily. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.themarketsdaily.com/2017/11/14/mediwound-ltd-mdwd-to-release-earnings-on-thursday.html.

About MediWound

MediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company’s product, NexoBrid, is indicated for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns.

Earnings History for MediWound (NASDAQ:MDWD)

Receive News & Ratings for MediWound Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediWound Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply